List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 34 studies with search of:   "Floxuridine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Drug: Floxuridine, Oxaliplatin, CPT-11;   Drug: Floxuridine, Oxaliplatin, CPT-11
2 Active, not recruiting Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: capecitabine;   Drug: floxuridine;   Drug: oxaliplatin
3 Active, not recruiting Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection
4 Completed Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: dexamethasone;   Drug: floxuridine;   Drug: irinotecan hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery
5 Recruiting Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Condition: Liver Cancer
Interventions: Drug: bevacizumab;   Drug: dexamethasone;   Drug: floxuridine;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: flow cytometry;   Procedure: immunoenzyme technique;   Procedure: immunohistochemistry staining method;   Procedure: immunologic technique;   Procedure: laboratory biomarker analysis;   Procedure: protein expression analysis
6 Completed Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
Condition: Cancer
Interventions: Drug: floxuridine;   Drug: leucovorin calcium;   Drug: oxaliplatin
7 Completed Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Treating Patients With Primary Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: dexamethasone;   Drug: floxuridine;   Procedure: comparative genomic hybridization;   Procedure: conventional surgery;   Procedure: cytogenetic analysis
8 Active, not recruiting A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Condition: Hepatic Cancer
Intervention: Drug: FLOXURIDINE
9 Completed A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Conditions: Colorectal Neoplasm;   Liver Neoplasm;   Neoplasm Metastasis
Interventions: Drug: Melphalan;   Drug: Floxuridine;   Drug: Leucovorin
10 Recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy and Bevacizumab in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: bevacizumab;   Drug: dexamethasone;   Drug: floxuridine;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
11 Active, not recruiting Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: conventional surgery
12 Recruiting Intraperitoneal Floxuridine in Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: fluorodeoxyuridine (FUDR)
13 Recruiting Radiolabeled Monoclonal Antibody, Gemcitabine, and Hepatic Arterial Infusion of Floxuridine in Treating Patients With Metastatic Colorectal Cancer and Liver Metastases
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: gemcitabine hydrochloride;   Drug: yttrium Y 90 anti-CEA monoclonal antibody cT84.66;   Procedure: adjuvant therapy;   Procedure: high performance liquid chromatography;   Procedure: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Procedure: pharmacological study;   Procedure: proteomic profiling
14 Completed Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: irinotecan hydrochloride;   Procedure: adjuvant therapy
15 Active, not recruiting Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
Conditions: Colorectal Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: floxuridine
16 Active, not recruiting Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: fluorouracil;   Procedure: conventional surgery;   Procedure: radiofrequency ablation
17 Recruiting Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: floxuridine;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy
18 Active, not recruiting Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: cisplatin;   Drug: floxuridine;   Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: conventional surgery
19 Active, not recruiting Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: FOLFOX regimen;   Drug: dexamethasone;   Drug: floxuridine;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
20 Active, not recruiting Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Drug: floxuridine;   Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: conventional surgery

Previous Page Studies Shown (1-20) Next (21-34)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services